Evidence-Based Complementary and Alternative Medicine

Research Article

The Role of Xuefu Zhuyu Decoction in Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention

Table 3

Results of multivariate linear regression (95% confidence interval of regression coefficient).
VariablesInterventionMaleSmokingWeightAge
eGFR72h20.76 (19.54, 21.98)18.79 (17.10, 20.49)1.96 (0.44, 3.48)0.09 (0.02, 0.17)−0.53 (−0.60, −0.46)
SCr72h−13.37 (−14.47, −12.27)———0.32 (0.25, 0.38)
SOD72h29.39 (28.42, 30.35)11.21 (10.24, 12.19)——−0.33 (−0.38, −0.28)
MDA72h−2.44 (−2.52, −2.37)−0.88 (−0.95, −0.80)——0.03 (0.02, 0.03)
eGFR72h: eGFR at 72 h after PCI; SCr72h: SCr at 72 h after PCI; SOD72h: SOD at 72 h after PCI; MDA72h: MDA at 72 h after PCI. Adjusting for hypertension, diabetes, previous myocardial infarction, multivessel disease, contrast volume, and LVEF.